Lipid peroxidation in the body of patients with tuberculosis

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This work was aimed to the comparative assessment of the activity of free-radical lipid oxidation in the body of tuberculosis patients and healthy volunteers. The study involved 76 patients with drug-susceptible and drug-resistant pulmonary tuberculosis (mean age 42.97±15.38 years) and 40 relatively healthy volunteers (mean age 42.45±11.56 years). Venous blood samples were used for the study. Malondialdehyde concentration was determined in blood serum (Costa et al. [2006]); the activity of enzymes of the glutathione system – glutathione peroxidase (Paglia et al., [1967]), glutathione-S-transferase (Habig et al. [1974]), glutathione reductase (Mannervik et al. [1978]) and the concentration of reduced glutathione (Tietze et al. [1969]) – was determined in erythrocyte hemolysate According to the results of our study, in the body of patients with tuberculosis, there is an increase in the intensity of free-radical oxidation against the background of a decrease in antioxidant protection. The intensity of free-radical lipid oxidation and the indices of the glutathione system among patients with drug-sensitive and drug-resistant pulmonary tuberculosis did not differ significantly.

Full Text

Restricted Access

About the authors

E. K. Rumyantsev

Yakutsk Scientific Center for Complex Medical Problems

Author for correspondence.
Email: Tzeentch1993@mail.ru
ORCID iD: 0000-0001-9843-3098
SPIN-code: 1081-6314

Junior Researcher at the Arctic Medical Center

Russian Federation, Yakutsk

N. M. Krasnova

M.K. Ammosov North-Eastern Federal University

Email: Tzeentch1993@mail.ru
ORCID iD: 0000-0002-4811-7801
Russian Federation, Yakutsk

V. M. Nikolaev

Yakutsk Scientific Center for Complex Medical Problems

Email: Tzeentch1993@mail.ru
ORCID iD: 0000-0003-4490-8910
Russian Federation, Yakutsk

E. S. Prokopiev

E.N. Andreev Scientific and Practical Center “Phthisiology”

Email: Tzeentch1993@mail.ru
ORCID iD: 0000-0001-7489-9221
Russian Federation, Yakutsk

M. P. Kirillina

Yakutsk Scientific Center for Complex Medical Problems

Email: Tzeentch1993@mail.ru
ORCID iD: 0000-0002-8629-1296
Russian Federation, Yakutsk

D. A. Sychev

Russian Medical Academy of Continuous Professional Education

Email: Tzeentch1993@mail.ru
ORCID iD: 0000-0002-4496-3680
Russian Federation, Moscow

References

  1. Global tuberculosis report 2022 URL: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022
  2. Даренская М.А., Колесникова Л.И., Колесников С.И. Свободнорадикальные реакции при социально значимых инфекционных заболеваниях: Вич-инфекции, Гепатитах, туберкулезе. Вестник РАМН. 2020;3:196–203. [Darenskaya M.A., Kolesnikova L.I., Kolesnikov S.I. Free radical reactions in socially significant infectious diseases: HIV infection, Hepatitis, tuberculosis. Vestnik RАМN=Bulletin of the Russian Academy of Medical Sciences. 2020;3:196–203. (In Russ.)].
  3. Singh R., Dwivedi S.P., Gaharwar U.S,. et al. Recent updates on drug resistance in Mycobacterium tuberculosis. J Appl Microbiol. 2020;128(6):1547–67. doi: 10.1111/jam.14478.
  4. Соловьева С.А. Характеристические профили биологически активных веществ образцов плазмы крови больных туберкулезом, полученные методом ВЭЖХ. Журнал аналитической химии. СПб., 2019;74(6):421–25. [Solovieva S.A. Characteristic profiles of biologically active substances of blood plasma samples of tuberculosis patients obtained by HPLC. Zhurnal analiticheskoi khimii=Journal of Analytical Chemistry. St. Petersburg, 2019;74(6):421–25. (In Russ.)].
  5. Abulfathi A.A., Decloedt E.H., Svensson E.M., Diacon A.H., Donald P., Reuter H. Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis. Clin Pharmacokinet. 2019;58(9):1103–29. doi: 10.1007/s40262-019-00764-2. PMID: 31049868.
  6. Stehr M., Elamin A.A., Singh M. Pyrazinamide: the importance of uncovering the mechanisms of action in mycobacteria. Expert Rev Anti Infect Ther. 2015;13(5):593–603. doi: 10.1586/14787210.2015.1021784.
  7. Chowdhury A.S., Khaledian E., Broschat S.L. Capreomycin resistance prediction in two species of Mycobacterium using a stacked ensemble method. J Appl Microbiol. 2019 Dec;127(6):1656–64. doi: 10.1111/jam.14413.
  8. Yun H.Y., Chang M.J., Jung H., et al. Prothionamide Dose Optimization Using Population Pharmacokinetics for Multidrug-Resistant Tuberculosis Patients. Antimicrob Agents Chemother. 2022;66(9):e0189321. doi: 10.1128/aac.01893-21.
  9. Deshpande D., Pasipanodya J.G., Mpagama S.G., et al. Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis. Clin Infect Dis. 2018;67(suppl_3):S293-S302. doi: 10.1093/cid/ciy611.
  10. Shee S., Singh S., Tripathi A., et al. Moxifloxacin-Mediated Killing of Mycobacterium tuberculosis Involves Respiratory Downshift, Reductive Stress, and Accumulation of Reactive Oxygen Species. Antimicrob Agents Chemother. 2022;66(9):e0059222. doi: 10.1128/aac.00592-22.
  11. Kishor K., Dhasmana N., Kamble S.S., Sahu R.K. Linezolid Induced Adverse Drug Reactions – An Update. Curr Drug Metab. 2015;16(7):553–59. Doi: 10.2174/ 1389200216666151001121004.
  12. Yew W.W., Chang K.C., Chan D.P. Oxidative Stress and First-Line Antituberculosis Drug-Induced Hepatotoxicity. Antimicrob Agents Chemother. 2018;62(8):e02637-17. doi: 10.1128/AAC.02637-17. Erratum in: Antimicrob Agents Chemother. 2018 Sep 24;62(10):
  13. Forman H.J., Zhang H., Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30(1-2):1-12. doi: 10.1016/j.mam. 2008.08.006.
  14. Wu G., Fang Y.Z., Yang S., et al. Glutathione metabolism and its implications for health. J Nutr. 2004;134(3):489–92. doi: 10.1093/jn/134.3.489.
  15. Costa C.M., Santos R.C.C., eLima E.S. A simple automated procedure for thiol measurement in human serum samples. J Bras Patol Med Lab 2006;42:345–50.
  16. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Analytical Biochemistry. 1969;27(3):502–22. doi: 10.1016/0003-2697(69)90064-5.
  17. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158–69.
  18. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249(22):7130-9.
  19. Boggaram V., Larson K.&Mannervik B. Characterization of glutathione reductase from porcine erythrocytes. Biochimica et Biophysica Acta (BBA) – Enzymology. 1978;527(2):337–37. doi: 10.1016/0005-2744(78)90348-0.
  20. Dharmaraja A.T. Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria. J Med Chem. 2017;60(8):3221–40. doi: 10.1021/acs.jmedchem.6b01243.
  21. Разыграев А.В., Матросова М.О., Титович И.А. Роль глутатионпероксидаз в ткани эндометрия: факты, гипотезы, перспективы изучения. Журнал акушерства и женских болезней. 2017;66(2):104–11. [Razygraev A.V., Matrosova M.O., Titovich I.A. The role of glutathione peroxidases in endometrial tissue: facts, hypotheses, prospects for study. Zhurnal akusherstva i zhenskikh boleznei. 2017;66(2):104–11. (In Russ)].
  22. Калинина Е.В. Роль глутатиона, глутатион трансферазы и глутаредоксина в регуляции редокс-зависимых процесов. Успехи биологической химии. 2014;54:299–348. [Kalinina E.V. The role of glutathione, glutathione transferase and glutaredoxin in the regulation of redox-dependent processes. Uspekhi biologicheskoi khimii. 2014;54:299–348. (In Russ)].
  23. Deponte M. Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes. Biochimica et Biophysica Acta (BBA) – General Subjects. 2013;1830(5):3217–66. doi: 10.1016/j.bbagen.2012.09.018.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies